Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Mesenchymal Stem Cells
100%
Therapeutic Outcome
100%
Experimental Autoimmune Encephalomyelitis
100%
Toll-like Receptor 4 (TLR4)
100%
Therapeutic Effect
18%
Autoimmune Disease
12%
Inflammatory Diseases
12%
Suppression Effect
12%
Single Stimulus
12%
Therapeutic Action
6%
Therapeutic Potential
6%
Cell-based
6%
Cell Therapy
6%
Mouse Model
6%
Suppressive Activity
6%
Inducible Nitric Oxide Synthase
6%
Proliferation in Vitro
6%
T Cell Proliferation
6%
Exposure Time
6%
Differential Activation
6%
Treg
6%
Immune Parameters
6%
Short-term Exposure
6%
Toll-like
6%
Matters of Concern
6%
Clinical Protocols
6%
Poly IC
6%
Biological Response
6%
Phenotypic Change
6%
Cell Surface Display
6%
Long-term Exposure
6%
Experimental Autoimmune Encephalomyelitis Mice
6%
Anti-inflammatory Capacity
6%
TLR4 Expression
6%
Toll-like Receptor 3 (TLR3)
6%
Pro-inflammatory Phenotype
6%
TLR4 Receptor
6%
Pharmacology, Toxicology and Pharmaceutical Science
Toll Like Receptor 4
100%
Experimental Autoimmune Encephalomyelitis
100%
Immunosuppressive Agent
50%
Therapeutic Effect
50%
Inflammatory Disease
33%
Autoimmune Disease
33%
Anti-Inflammatory Drug
33%
Mouse Model
16%
Receptor
16%
Polyinosinic Polycytidylic Acid
16%
Toll Like Receptor
16%
Toll Like Receptor 3
16%
Neuroscience
Mesenchymal Stem Cell
100%
Experimental Autoimmune Encephalomyelitis
100%
TLR 4
100%
In Vitro
31%
Immunosuppressive Drug
18%
Anti-Inflammatory
12%
Cell Therapy
12%
Autoimmune Disease
12%
In Vivo
6%
Cell Proliferation
6%
Polyinosinic:polycytidylic Acid
6%
Toll-Like Receptor
6%
TLR 3
6%
T Cell
6%
Receptor
6%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Experimental Autoimmune Encephalomyelitis
100%
TLR4
100%
Immunosuppressive Drug
18%
Autoimmune Disease
12%
Mouse Model
6%
Regulatory T Cell
6%
T Cell Proliferation
6%
Toll-Like Receptor
6%
Polyinosinic:polycytidylic Acid
6%
TLR3
6%
Immunity
6%